Cardiac Ablation Market

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Factor Analysis
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
           2.2.3 Supply-Side Analysis
    2.3 Market Size Estimation
           2.3.1 Top-Down Approach
           2.3.2 Bottom-Up Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 History, Evolution, and Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Product
           5.2.3 Market, By Application
    5.3 Market Evolution
    5.4 Market Dynamics
           5.4.1 Key Market Drivers
           5.4.2 Key Market Restraints
           5.4.3 Key Market Opportunities
           5.4.4 Key Market Challenges

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Cardiac Ablation Market, By Technology
    7.1 Introduction
    7.2 Radiofrequency (RF) Ablation
    7.3 Electrical Ablation
    7.4 Cryoablation
    7.5 Ultrasound Ablation
    7.6 Microwave Ablation

8 Cardiac Ablation Market, By Product
    8.1 Introduction
    8.2 Radiofrequency (RF) Ablators
           8.2.1 Temperature-Controlled Radiofrequency Ablators
           8.2.2 Fluid-Cooled Radiofrequency Ablators
           8.2.3 Robotic Catheter Manipulation Systems
    8.3 Electrical Ablators
           8.3.1 Argon Plasma/Beam Coagulators
           8.3.2 Irreversible Electroporation Ablators
    8.4 Cryoablation Devices
           8.4.1 Tissue Contact Probes
           8.4.2 Tissue Spray Probes
    8.5 Ultrasound Ablators
           8.5.1 High-Intensity Focused Ultrasound Ablators
           8.5.2 Magnetic Resonance Guided Focused Ultrasound Ablators
           8.5.3 Ultrasound Ablation Systems
    8.6 Microwave Ablators
           8.6.1 Microwave Thermotherapy Devices

9 Cardiac Ablation Market, By Application
    9.1 Introduction
    9.2 Cardiac Rhythm Management
           9.2.1 Cardiac Arrythmia
           9.2.2 Atrial Fibrillation and Flutter
           9.2.3 Tachycardia
    9.3 Open Surgery
    9.4 Others

10 Cardiac Ablation Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (Row)

11 Competitive Landscape
     11.1 Introduction
     11.2 Market Share Analysis, By Key Players
     11.3 Competitive Scenario
     11.4 Recent Developments
             11.4.1 New Products Launches and Product Enhancements
             11.4.2 Agreements, Partnerships, and Agreements
             11.4.3 Mergers and Acquisitions
             11.4.4 Geographic Expansions
             11.4.5 Other Developments

12 Compny Profiles*
     12.1 Introduction
     12.2 Advanced Cardiac Therapeutics 
             12.2.1 Business Overview**
             12.2.2 Financial Overview
             12.2.3 Product Portfolio
             12.2.4 Key Strategies
             12.2.5 Recent Developments
     12.3 Alcon Laboratories Inc.
     12.4 Angiodynamics, Inc. 
     12.5 Atricure, Inc. 
     12.6 Biosense Webster (A Subsidiary of Johnson & Johnson Inc.)
     12.7 Boston Scientific Corporation
     12.8 Conmed Corporation
     12.9 Medtronic, PLC
     12.10 Olympus Corporation
     12.11 St. Jude Medical, Inc.

13 Appendix
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.